Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
SCHEDULE OF OTHER CURRENT ASSETS

Other current assets consisted of the following as of September 30, 2022 and December 31, 2021:

 

    September 30, 2022     December 31, 2021  
      (unaudited)          
Lab supply inventory   $ 1,246     $ 825  
Prepaid expenses     226       584  
Other     138       70  
Total other current assets   $ 1,610     $ 1,479  
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE

 

    2022     2021     2022     2021  
    Three Months     Nine Months Ended  
    Ended September 30,     Ended September 30,  
    2022     2021     2022     2021  
    (unaudited)           (unaudited)        
Basic weighted average number of common shares     4,242       4,165       4,227       4,119  
Potential dilutive effect of stock-based awards     -       -       -       -  

Diluted weighted average number of common shares

     4,242       4,165       4,227       4,119  
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

 

    2022     2021     2022     2021  
    Three Months     Nine Months Ended  
    Ended September 30,     Ended September 30,  
    2022     2021     2022     2021  
    (unaudited)     (unaudited)  
Options     578       684       578       684  
Restricted stock units (RSUs)     340       366       340       366  
Warrants     54       1,405       54       1,405  
Antidilutive securities excluded from computation of earnings per share     972       2,455       972       2,455